Marcato P - Search Results

1

Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.

Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, Giacomantonio CA, Lee PW. Marcato P, et al. Stem Cells. 2011 Jan;29(1):32-45. doi: 10.1002/stem.563. Stem Cells. 2011. PMID: 21280157

2

Connecting reovirus oncolysis and Ras signaling.

Marcato P, Shmulevitz M, Lee PW. Marcato P, et al. Cell Cycle. 2005 Apr;4(4):556-9. doi: 10.4161/cc.4.4.1600. Epub 2005 Apr 10. Cell Cycle. 2005. PMID: 15753655 Review.

3

Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer.

Shmulevitz M, Marcato P, Lee PW. Shmulevitz M, et al. Among authors: marcato p. Oncogene. 2005 Nov 21;24(52):7720-8. doi: 10.1038/sj.onc.1209041. Oncogene. 2005. PMID: 16299532 Review.

4

Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release.

Marcato P, Shmulevitz M, Pan D, Stoltz D, Lee PW. Marcato P, et al. Mol Ther. 2007 Aug;15(8):1522-30. doi: 10.1038/sj.mt.6300179. Epub 2007 Apr 24. Mol Ther. 2007. PMID: 17457318 Free article.

5

Oncolytic reovirus effectively targets breast cancer stem cells.

Marcato P, Dean CA, Giacomantonio CA, Lee PW. Marcato P, et al. Mol Ther. 2009 Jun;17(6):972-9. doi: 10.1038/mt.2009.58. Epub 2009 Mar 17. Mol Ther. 2009. PMID: 19293772 Free PMC article.

6

Activated Ras signaling significantly enhances reovirus replication and spread.

Shmulevitz M, Marcato P, Lee PW. Shmulevitz M, et al. Among authors: marcato p. Cancer Gene Ther. 2010 Jan;17(1):69-70. doi: 10.1038/cgt.2009.46. Cancer Gene Ther. 2010. PMID: 19590528 No abstract available.

7

If cancer stem cells are resistant to current therapies, what's next?

Marcato P, Dean CA, Giacomantonio CA, Lee PW. Marcato P, et al. Future Oncol. 2009 Aug;5(6):747-50. doi: 10.2217/fon.09.58. Future Oncol. 2009. PMID: 19663722 No abstract available.

8

Targeting cancer-initiating cells with oncolytic viruses.

Cripe TP, Wang PY, Marcato P, Mahller YY, Lee PW. Cripe TP, et al. Among authors: marcato p. Mol Ther. 2009 Oct;17(10):1677-82. doi: 10.1038/mt.2009.193. Epub 2009 Aug 11. Mol Ther. 2009. PMID: 19672244 Free PMC article. Review.

9

Reovirus virotherapy overrides tumor antigen presentation evasion and promotes protective antitumor immunity.

Gujar SA, Marcato P, Pan D, Lee PW. Gujar SA, et al. Among authors: marcato p. Mol Cancer Ther. 2010 Nov;9(11):2924-33. doi: 10.1158/1535-7163.MCT-10-0590. Epub 2010 Oct 26. Mol Cancer Ther. 2010. PMID: 20978162

10

Oncolytic virus-initiated protective immunity against prostate cancer.

Gujar SA, Pan DA, Marcato P, Garant KA, Lee PW. Gujar SA, et al. Among authors: marcato p. Mol Ther. 2011 Apr;19(4):797-804. doi: 10.1038/mt.2010.297. Epub 2011 Jan 18. Mol Ther. 2011. PMID: 21245852 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters